Search results
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 2 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 3 days agoYounger children, adults 65 and older and immunocompromised people may need multiple doses, the...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 2 days agoThe stock remains significantly volatile. While the positive news relating to Sanofi has lifted Novavax's share price recently, over time, that effect...
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June...
Benzinga· 7 days agoMid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX,...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 1 day agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 20 hours agoA new strain of COVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall. The U.S. Food and Drug Administration ...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA TODAY via Yahoo News· 6 days agoBoth vaccines have been independently tested and yielded...H1N1, H3N2 and B/Victoria, Moderna said in a news release. Moderna expects to present the Phase 3 study data at ...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 6 days agoModerna representatives told news outlets that the company aspires to have the new shot approved by...
